KLKBY yields 2.34% · PFE yields 6.13%● Live data
📍 KLKBY pulled ahead of the other in Year 1
Combined, KLKBY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KLKBY + PFE for your $10,000?
Kuala Lumpur Kepong Berhad engages in the plantation, manufacturing, and property development businesses. The company operates through Plantation, Manufacturing, Property Development, Investment Holding, and Others segments. It is involved in the cultivation, processing, and marketing of palm and rubber products; extraction of crude palm oil; refining of palm products; kernel crushing and trading of palm products; manufacturing and trading in oleochemicals, fatty acids, glycerin, industrial amides, fatty alcohol and methyl esters, non-ionic surfactants and esters, soap noodles, triacetin, special paper chemicals and surfactants, and palm phytonutrients and other palm derivatives; detergents, auxiliary materials for detergents and cosmetics, and basic organic chemicals from agricultural products; and alcohol ether sulphates, alcohol sulphates, and sulphonic acids. The company also provides rubber gloves, parquet flooring products, pharmaceutical and bio-pharmaceutical intermediates, and fine chemicals, as well as stores and distributes bulk liquid. In addition, it engages in farming and management services; and agronomic service and research, as well as operates biogas power plants; and develops residential and commercial properties. Further, the company operates holiday bungalows; manages properties; manufactures jams and preserves; and offers offshore captive insurance and logistics services related to palm products. It operates in Malaysia, Far East, the Middle East, South East Asia, Southern Asia, Europe, North America, South America, Australia, Africa, and internationally. The company was founded in 1906 and is based in Ipoh, Malaysia.
Full KLKBY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.